< previous page page_199 next page >

Page 199
6fb6ffc4153cdc534470145c4eef46f0.gif
198. E. Hurwitz. Cancer Reds. 35: 1175, 1975.
6fb6ffc4153cdc534470145c4eef46f0.gif
199. H. E. Blythman, et al. Nature 290: 145, 1981.
6fb6ffc4153cdc534470145c4eef46f0.gif
200. I. S. Trowbridge and D. L. Domingo. Nature 294: 171, 1981.
6fb6ffc4153cdc534470145c4eef46f0.gif
201. T. Ghose and S. P. Nigam. Cancer 29: 1398, 1972.
6fb6ffc4153cdc534470145c4eef46f0.gif
202. L. D. Leserman, et al. Nature 288: 602, 1980.
6fb6ffc4153cdc534470145c4eef46f0.gif
203. G. M. Barratt, et al. Biochem. Soc. Trans. 12: 348, 1984.
6fb6ffc4153cdc534470145c4eef46f0.gif
204. G. F. Rowland, et al. Nature 255: 487, 1975.
6fb6ffc4153cdc534470145c4eef46f0.gif
205. M. V. Primm, et al. Cancer Immunol. Immunother. 12: 125, 1982.
6fb6ffc4153cdc534470145c4eef46f0.gif
206. D. G. Gilliland, et al. Nat. Acad. Sci. USA 77: 4539, 1980.
6fb6ffc4153cdc534470145c4eef46f0.gif
207. G. F. Rowland, et al. Cancer Immunol. Immunother. 19: 1, 1985.
6fb6ffc4153cdc534470145c4eef46f0.gif
208. P. A. Trail, et al. Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates. Science 261: 212, 1993.
6fb6ffc4153cdc534470145c4eef46f0.gif
209. I. Hellstrom, et al. Cancer Res. 50: 2183, 1990.
6fb6ffc4153cdc534470145c4eef46f0.gif
210. H. Zhao, et al. Determination of Immunoreactivity of Doxorubicin Antibody Immunoconjugates by a Ley Competitive RIA. Bioconjugate Chem. 3: 549, 1992.
6fb6ffc4153cdc534470145c4eef46f0.gif
211. H. Zhao, et al. Immunoreactivity and Antigen-Specific Cytotoxicity of BR96 Immunoconjugates Synthesized from a New Heterobifunctional Linker, 6-Male-Imidocaproylhydrazone of Doxorubicin. Proc. Am. Assoc. Cancer Res. 35: 502, 1994.
6fb6ffc4153cdc534470145c4eef46f0.gif
212. D. Willner, et al. 6-Maleimidocaproylhydrazone of DoxorubicinA New Derivative for the Preparation of Immunoconjugates of Doxorubicin. Bioconjugate Chem. 4: 521, 1993.
6fb6ffc4153cdc534470145c4eef46f0.gif
213. J. Garrigues, et al. Am. J. Pathol. 142: 607, 1993.
6fb6ffc4153cdc534470145c4eef46f0.gif
214. E. Kanabrocki, et al. Circadian variation in presumably healthy young soldiers, U.S. Department of Commerce, Doc. No. PB228427. National Technical Information Service, P.O. Box 51553, Springfield, VA (1974).
6fb6ffc4153cdc534470145c4eef46f0.gif
215. F. Halberg, et al. Blood pressure assessment in a broad chronobiologic perspective. In Heart and Brain. H. Refsum, Ed. Springer-Verlag, Berlin, 1988.
6fb6ffc4153cdc534470145c4eef46f0.gif
216. E. Halberg, et al. Plexo-serial linear-nonlinear rhythmometry of blood pressure, pulse, and motor activity by a couple in their 60's. Chronobiologia 8: 351, 1981.
6fb6ffc4153cdc534470145c4eef46f0.gif
217. D. Krieger. Rhythms in CRF, ACTH and Corticosteroids in Endocrine Rhythms. D. Krieger, Ed. Raven Press, New York, 1979.
6fb6ffc4153cdc534470145c4eef46f0.gif
218. D. Lang, et al. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30: 435, 1981.
6fb6ffc4153cdc534470145c4eef46f0.gif
219. J. Stagner, et al. Sustained oscillations of insulin, glucagon and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration. J. Clin. Invest. 65: 939, 1980.
6fb6ffc4153cdc534470145c4eef46f0.gif
220. A. Murdoch, et al. Determination of the frequency of pulsatile luteinizing hormone secretion by time series analysis. Clin. Endocrinol. 22: 341, 1985.
6fb6ffc4153cdc534470145c4eef46f0.gif
221. D. Koerker, et al. Synchronous sustained oscillation of C-peptide and insulin in the plasma of fasting monkeys. Endocrinology 102: 1649, 1978.
6fb6ffc4153cdc534470145c4eef46f0.gif
222. Y. Honda, et al. Growth hormone secretion during sleep in normal subjects. J. Clin. Endocrinol. Metab. 29: 20, 1969.
6fb6ffc4153cdc534470145c4eef46f0.gif
223. A. Frantz. Rhythms in prolactin secretion. In Endocrine Rhythms. D. Krieger, Ed. Raven Press, New York, 1979.

 
< previous page page_199 next page >